Emergency use nod to Bharat Biotech's Covaxin: WHO's Technic

The technical panel had earlier sought additional clarifications from Bharat Biotech, the manufacturer of Covaxin, in order to conduct a final Emergency Use Listing (EUL) risk-benefit assessment for global use of the vaccine.

Related Keywords

India , New Delhi , Delhi , Bharat , , Pfizer , Bio Serum Institute Of India , Astrazeneca , Serum Institute , Technical Advisory Group For Emergency Use Listing , Technical Advisory Group , World Health Organisation , Bharat Biotech , Emergency Use Listing , Covaxin , Who , Emergency Use Authorisation , Covid 19 ,